1. Home
  2. RAPP vs PCRX Comparison

RAPP vs PCRX Comparison

Compare RAPP & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPP
  • PCRX
  • Stock Information
  • Founded
  • RAPP 2022
  • PCRX 2006
  • Country
  • RAPP United States
  • PCRX United States
  • Employees
  • RAPP N/A
  • PCRX N/A
  • Industry
  • RAPP
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAPP
  • PCRX Health Care
  • Exchange
  • RAPP Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • RAPP 844.6M
  • PCRX 604.7M
  • IPO Year
  • RAPP 2024
  • PCRX 2011
  • Fundamental
  • Price
  • RAPP $12.69
  • PCRX $20.55
  • Analyst Decision
  • RAPP Strong Buy
  • PCRX Buy
  • Analyst Count
  • RAPP 4
  • PCRX 10
  • Target Price
  • RAPP $37.33
  • PCRX $27.60
  • AVG Volume (30 Days)
  • RAPP 125.2K
  • PCRX 779.4K
  • Earning Date
  • RAPP 02-10-2025
  • PCRX 02-27-2025
  • Dividend Yield
  • RAPP N/A
  • PCRX N/A
  • EPS Growth
  • RAPP N/A
  • PCRX N/A
  • EPS
  • RAPP N/A
  • PCRX N/A
  • Revenue
  • RAPP N/A
  • PCRX $694,957,000.00
  • Revenue This Year
  • RAPP N/A
  • PCRX $4.83
  • Revenue Next Year
  • RAPP N/A
  • PCRX $2.16
  • P/E Ratio
  • RAPP N/A
  • PCRX N/A
  • Revenue Growth
  • RAPP N/A
  • PCRX 4.40
  • 52 Week Low
  • RAPP $12.09
  • PCRX $11.16
  • 52 Week High
  • RAPP $29.74
  • PCRX $34.01
  • Technical
  • Relative Strength Index (RSI)
  • RAPP N/A
  • PCRX 61.87
  • Support Level
  • RAPP N/A
  • PCRX $18.18
  • Resistance Level
  • RAPP N/A
  • PCRX $22.36
  • Average True Range (ATR)
  • RAPP 0.00
  • PCRX 0.97
  • MACD
  • RAPP 0.00
  • PCRX 0.11
  • Stochastic Oscillator
  • RAPP 0.00
  • PCRX 56.80

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: